Found: 12
Select item for more details and to access through your institution.
Traceless Bioresponsive Shielding of Adenovirus Hexon with HPMA Copolymers Maintains Transduction Capacity In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0082716
- By:
- Publication type:
- Article
Transcellular Targeting of Fiber- and Hexon-Modified Adenovirus Vectors across the Brain Microvascular Endothelial Cells In Vitro.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045977
- By:
- Publication type:
- Article
The evolution of the huntingtin-associated protein 40 (HAP40) in conjunction with huntingtin.
- Published in:
- BMC Evolutionary Biology, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12862-020-01705-5
- By:
- Publication type:
- Article
Process- and product-related impurities in the ChAdOxl nCov-19 vaccine.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.78513
- By:
- Publication type:
- Article
Vaccine-induced COVID-19 mimicry syndrome.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.74974
- By:
- Publication type:
- Article
High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
- Published in:
- Journal of Gene Medicine, 2011, v. 13, n. 12, p. 648, doi. 10.1002/jgm.1629
- By:
- Publication type:
- Article
ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum.
- Published in:
- Journal of Gene Medicine, 2011, v. 13, n. 12, p. 670, doi. 10.1002/jgm.1627
- By:
- Publication type:
- Article
Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.
- Published in:
- Journal of Gene Medicine, 2008, v. 10, n. 12, p. 1303, doi. 10.1002/jgm.1262
- By:
- Publication type:
- Article
miRNA-mediated Silencing in Hepatocytes Can Increase Adaptive Immune Responses to Adenovirus Vector-delivered Transgenic Antigens.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 8, p. 1547, doi. 10.1038/mt.2011.83
- By:
- Publication type:
- Article
Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 1, p. 83, doi. 10.1038/mt.2010.229
- By:
- Publication type:
- Article
Targeting of Adenovirus Vectors to the LRP Receptor Family With the High-affinity Ligand RAP via Combined Genetic and Chemical Modification of the pIX Capsomere.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 11, p. 1813, doi. 10.1038/mt.2008.174
- By:
- Publication type:
- Article
Fully Detargeted Polyethylene Glycol-coated Adenovirus Vectors Are Potent Genetic Vaccines and Escape from Pre-existing Anti-adenovirus Antibodies.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 1, p. 154, doi. 10.1038/sj.mt.6300306
- By:
- Publication type:
- Article